Boosters have been approved for all 3 COVID-19 vaccines (Pfizer, Moderna, and Johnson & Johnson).
FDA & CDC Authorize COVID-19 Boosters for Eligible Individuals
The FDA and CDC have authorized COVID-19 boosters for Pfizer, Moderna, and Johnson & Johnson recipients who meet the below criteria. See below for information on additional doses for moderate to severely immunocompromised individuals.
What’s the difference between a booster and an additional dose?
With news that the CDC is now recommending an additional, third dose of COVID-19 vaccine for select groups and the possibility that boosters are on the horizon in the next few weeks, how do you know the difference between the two, and why is there a distinction?
What’s the difference between a COVID-19 Booster and an Additional Dose?
The recently authorized additional dose of the COVID-19 vaccine is meant to specifically reach people who may not have a sufficient or expected immune response to the vaccine. Offering an additional dose can help strengthen the immune response to help ward off both infection and severity of infection.
Boosters on the other hand, are meant to address decreasing or waning vaccine effectiveness over time for people who had an expected immune response. Most studies continue to show that the COVID-19 vaccines are effective against COVID-19, particularly when it comes to severe infection and hospitalization.
Will boosters be authorized?
The Biden Administration announced this week that they’re likely to authorize boosters for COVID-19 vaccine recipients. The CDC and FDA have yet to weigh in on exactly who would qualify. More than likely the recommended rollout will be similar to the initial vaccine rollout, targeting health care workers, long-term care residents, and emergency workers before the broader population.
As always, Rite Aid, once authorized by the CDC, will continue to help administer the COVID-19 vaccine, additional doses, and boosters to help ensure the health and safety of our communities when we are able to do so.
Keep Up the Prevention Measures
With the Delta variant driving up infections and cases across the country, getting vaccinated is the best way to protect yourself and your community along with mask-wearing and social distancing.
Rite Aid Booster Shots
Boosters can be administered at least 6 months after the 2nd dose of an initial series of Pfizer for individuals 16 years or older. Individuals 16-17 are only eligible for a Pfizer booster dose (no mixing and matching).
Boosters can be administered at least 6 months after the 2nd dose of initial series of Moderna or individuals 18 years or older. Moderna boosters will be administered at a half-dose volume compared to the initial series.
Johnson & Johnson/Janssen
Boosters can be administered at least 2 months after the initial Johnson & Johnson/Janssen shot was administered for anyone age 18+
You can Schedule your Rite Aid Booster Short By clicking on the button below.
Can I choose a different vaccine for a booster (mix & match)
It is recommended that you get a booster of the same COVID-19 vaccine brand that you received for your primary dose. The FDA or CDC have allowed for some recipients to receive an alternative brand from their initial series, but Rite Aid advises customers to have a conversation with their health provider or pharmacist to determine what’s best for them. Currently, you can schedule a booster for the same vaccine you received for your initial series. If a different one is needed, please talk to your pharmacist at the time of your appointment. Individuals 16-17 may only get a Pfizer booster.
Additional Doses for Immunocompromised
To meet the qualifications for an additional dose:
- Individuals who received either the Pfizer or Moderna COVID-19 vaccine at least 28 days prior
AND be considered moderately to severely immunocompromised as defined below:
- Had a solid organ transplant or recent hematopoietic malignancies
- Active or recent treatment for solid tumor hematologic malignancies (cancer)
- Severe primary immunodeficiency
- Advanced or untreated HIV
- Active treatment with high dose corticosteroids, alkylating agents, antimetabolites, TNF blockers, and other biologic agents
- Asplenia and chronic renal disease can be considered if condition is severe
Additional doses can be administered to Pfizer recipients ages 12+ or Moderna recipients ages 18+.
Moderately to severely immunocompromised individuals have not been approved for a booster shot after their third dose at this time.